AIM
Assured Investment Management Portfolio holdings
AUM
$79.5M
1-Year Return
105.2%
This Quarter Return
+7.15%
1 Year Return
+105.2%
3 Year Return
+53.61%
5 Year Return
+74.99%
10 Year Return
–
AUM
$4.37B
AUM Growth
+$995M
(+29%)
Cap. Flow
+$810M
Cap. Flow
% of AUM
18.53%
Top 10 Holdings %
Top 10 Hldgs %
21.73%
Holding
1,399
New
268
Increased
392
Reduced
456
Closed
268
Top Buys
| 1 |
KANG
iKang Healthcare Group, Inc.
KANG
|
+$131M |
| 2 |
Valero Energy
VLO
|
+$74.1M |
| 3 |
NFX
Newfield Exploration
NFX
|
+$66.4M |
| 4 |
Diamondback Energy
FANG
|
+$64.2M |
| 5 |
BP
BP
|
+$64.2M |
Top Sells
| 1 |
GNRT
Gener8 Maritime, Inc.
GNRT
|
+$44.3M |
| 2 |
CJ
C&J Energy Services, Inc.
CJ
|
+$26.6M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$21.9M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$21.2M |
| 5 |
ENDP
Endo International plc
ENDP
|
+$19.2M |
Sector Composition
| 1 | Energy | 23.67% |
| 2 | Consumer Discretionary | 12.88% |
| 3 | Industrials | 11.15% |
| 4 | Healthcare | 9.79% |
| 5 | Technology | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Anika Therapeutics
ANIK
$121M
| $315K | 0.01% |
9,849
-3,799
| -28% | -$122K |
|
902
Provident Financial Services
PFS
$2.59B
| $309K | 0.01% |
11,234
+3,788
| +51% | +$104K |
|
903
Factset
FDS
$13.7B
| $303K | 0.01% |
1,530
+1,310
| +595% | +$259K |
|
|
NXGN
904
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $303K | 0.01% |
15,545
-13,205
| -46% | -$257K |
|
905
Regions Financial
RF
$24.1B
| $300K | 0.01% |
16,880
-17,897
| -51% | -$318K |
|
906
Universal Insurance Holdings
UVE
$696M
| $300K | 0.01% |
8,553
-4,934
| -37% | -$173K |
|
907
Oxford Industries
OXM
$604M
| $296K | 0.01% |
3,571
-20,018
| -85% | -$1.66M |
|
908
Regenxbio
RGNX
$483M
| $295K | 0.01% |
4,111
-29,018
| -88% | -$2.08M |
|
|
MIME
909
DELISTED
Mimecast Limited
MIME
| $294K | 0.01% |
7,124
-18,643
| -72% | -$769K |
|
910
National Fuel Gas
NFG
$7.87B
| $290K | 0.01% |
+5,477
| New | +$290K |
|
911
Assembly Biosciences
ASMB
$171M
| $286K | 0.01% |
607
-1,089
| -64% | -$513K |
|
912
CACI
CACI
$10.7B
| $284K | 0.01% |
1,682
-797
| -32% | -$135K |
|
913
NovoCure
NVCR
$1.37B
| $281K | 0.01% |
8,974
-9,932
| -53% | -$311K |
|
|
RDUS
914
DELISTED
Radius Recycling
RDUS
| $275K | 0.01% |
8,151
+4,542
| +126% | +$153K |
|
915
Moelis & Co
MC
$5.44B
| $274K | 0.01% |
4,670
-4,768
| -51% | -$280K |
|
|
TGI
916
DELISTED
Triumph Group
TGI
| $274K | 0.01% |
+13,967
| New | +$274K |
|
917
Bank of New York Mellon
BK
$73.3B
| $271K | 0.01% |
5,019
-86,573
| -95% | -$4.67M |
|
918
Civitas Resources
CIVI
$3.13B
| $268K | 0.01% |
+7,077
| New | +$268K |
|
919
Matsons
MATX
$3.28B
| $268K | 0.01% |
6,992
-16,468
| -70% | -$631K |
|
920
Penumbra
PEN
$10.6B
| $267K | 0.01% |
+1,934
| New | +$267K |
|
|
MRTX
921
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $264K | ﹤0.01% |
5,347
+58
| +1% | +$2.86K |
|
922
Adient
ADNT
$1.92B
| $262K | ﹤0.01% |
+5,336
| New | +$262K |
|
923
CEVA Inc
CEVA
$549M
| $262K | ﹤0.01% |
8,689
+4,201
| +94% | +$127K |
|
924
HNI Corp
HNI
$2.06B
| $261K | ﹤0.01% |
7,013
-55
| -0.8% | -$2.05K |
|
925
US Physical Therapy
USPH
$1.23B
| $258K | ﹤0.01% |
2,691
+947
| +54% | +$90.8K |
|